Symptomatic treatment of benign prostatic obstruction with Nicergoline: A placebo controlled clinical study and urodynamic evaluation
โ Scribed by Ronchi, F. ;Margonato, A. ;Ceccardi, R. ;Rigatti, P. ;Rossini, B.M.
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 321 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
โฆ Synopsis
A double-blind crossover study of the alpha-blocker Nicergoline was carried out in sixteen patients affected by benign prostatic bladder outflow obstruction. The "irritative" symptoms of prostatic hypertrophy, including nocturnal frequency and dysuria, were improved after Nicergoline significantly more than after placebo. In 10 further patients with prostatic hypertrophy, peak and mean flow rates increased by 50% and 77% respectively after the acute administration of Nicergoline. No side effects were detected. In conclusion Nicergoline seems to be active and well tolerated in the treatment of benign prostatic obstruction.
๐ SIMILAR VOLUMES
## Abstract ## Aims We assessed the effects of onabotulinumtoxinA (BOTOXยฎ) on clinical and urodynamic variables in patients with idiopathic overactive bladder (OAB) and urinary urgency incontinence (UUI) with or without detrusor overactivity (DO), inadequately managed with anticholinergics. ## Me
One of the conclusions of this paper is that the Danish Prostatic Symptom score is a valid and sensitive questionnaire for the assessment of LUTS. We fully agree and recommend this questionnaire instead of the IPSS score, because it is more sensitive to changes after treatment/intervention [Flyger e
## Abstract Despite numerous publications and clinical trials, the results of treatment of recalcitrant chronic plantar fasciitis with extracorporeal shockwave therapy (ESWT) still remain equivocal as to whether or not this treatment provides relief from the pain associated with this condition. The